BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33245425)

  • 1. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
    Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
    Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.
    Bacon S; Kyithar MP; Rizvi SR; Donnelly E; McCarthy A; Burke M; Colclough K; Ellard S; Byrne MM
    Diabet Med; 2016 Jul; 33(7):976-84. PubMed ID: 26479152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturity onset diabetes of the young due to
    Pavić T; Juszczak A; Pape Medvidović E; Burrows C; Šekerija M; Bennett AJ; Ćuća Knežević J; Gloyn AL; Lauc G; McCarthy MI; Gornik O; Owen KR
    Biochem Med (Zagreb); 2018 Jun; 28(2):020703. PubMed ID: 29666556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
    Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
    Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturity onset diabetes of the young: identification and diagnosis.
    McDonald TJ; Ellard S
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):403-15. PubMed ID: 23878349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.
    Haring MPD; Vriesendorp TM; Klein Wassink-Ruiter JS; de Haas RJ; Gouw ASH; de Meijer VE
    Liver Int; 2019 Nov; 39(11):2042-2045. PubMed ID: 31483937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturity-onset diabetes of the young (MODY): an update.
    Anık A; Çatlı G; Abacı A; Böber E
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):251-63. PubMed ID: 25581748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
    Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P
    Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
    Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
    Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of young patients with HNF1A mutations (HNF1A-MODY).
    Raile K; Schober E; Konrad K; Thon A; Grulich-Henn J; Meissner T; Wölfle J; Scheuing N; Holl RW;
    Diabet Med; 2015 Apr; 32(4):526-30. PubMed ID: 25483937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturity onset diabetes of the young: Seek and you will find.
    Heuvel-Borsboom H; de Valk HW; Losekoot M; Westerink J
    Neth J Med; 2016 Jun; 74(5):193-200. PubMed ID: 27323672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.
    Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S
    Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical data.
    Giuffrida FMA; Moises RS; Weinert LS; Calliari LE; Manna TD; Dotto RP; Franco LF; Caetano LA; Teles MG; Lima RA; Alves C; Dib SA; Silveiro SP; Dias-da-Silva MR; Reis AF;
    Diabetes Res Clin Pract; 2017 Jan; 123():134-142. PubMed ID: 28012402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic characterization and long-term evaluation of individuals with maturity-onset diabetes of the young (MODY): The journey towards appropriate treatment.
    Campos Franco P; Santos de Santana L; Dantas Costa-Riquetto A; Santomauro Junior AC; Jorge AAL; Gurgel Teles M
    Diabetes Res Clin Pract; 2022 May; 187():109875. PubMed ID: 35472491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic ketoacidosis in the setting of HNF1A-maturity onset diabetes of the young.
    Egan AM; Cunningham A; Jafar-Mohammadi B; Dunne FP
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25837654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.